Atlas Venture Associates XI, LLC is 10% Owner at Dyne Therapeutics, Inc. (DYN). They have made 1 open-market trade across 1 company since 2021, most recently 2024-02-23.
CIK 0001780067
1 open-market purchase totalling $4.0M since 2021, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.